Latanoprost en nanoemulsión: una nueva opción terapéutica

Estudio clínico

3389 3390 3378 3379

Palabras claves:

BAK-free, glaucoma, latanoprost, nanoemulsion, superficieocular, toxicidad

Estudios relacionados

(2018) Efficacy and tolerability of a new thermostable formulation of latanoprost in nanoparticles

Efficacy and safety of an innovative formulation of benzalkonium chloride-free latanoprost for the treatment of open-angle glaucoma

A Comparative Study of Difluprednate 0.05% Nanoemulsion Vs Prednisolone Acetate 1% + Phenylephrine 0.12% Suspension on Postoperative Inflammation Treatment Following Cataract Surgery

Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis

Efficacy and Tolerability of a New Latanoprost 0.005%BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial

Difluprednate 0.05% twice a day vs prednisolone acetate 1% 4 times a day forcataract postsurgical inflammation treatment:noninferiority trial